Filed Pursuant to Rule 424(b)(2)
Registration Statement No. 333-284698
333-284698-01
The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion, dated February 5, 2025
PRELIMINARY PROSPECTUS SUPPLEMENT
(To prospectus dated February 5, 2025)
![LOGO](https://capedge.com/proxy/424B2/0001193125-25-020537/g846011g49a01.jpg)
EMBRAER NETHERLANDS FINANCE B.V.
(a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of the Netherlands)
US$
% Notes due
Fully, unconditionally and irrevocably guaranteed by
EMBRAER S.A.
(incorporated in the Federative Republic of Brazil)
Embraer Netherlands Finance B.V., or the issuer, is offering US$ in aggregate principal amount of its % notes due , or the notes. The issuer is a private company with limited liability incorporated under the laws of the Netherlands. The notes will be fully, unconditionally and irrevocably guaranteed by Embraer S.A., or Embraer, a corporation (sociedade anônima) incorporated under the laws of the Federative Republic of Brazil.
Interest on the notes will be payable semi-annually on and of each year, commencing on , 2025.
The issuer may, at its option, redeem the notes, in whole or in part, at any time, by paying the greater of (i) 100% of the principal amount of the notes and (ii) the applicable “make-whole” amount. The notes may also be redeemed by either the issuer or Embraer (as the case may be), in whole but not in part, at 100% of their principal amount plus accrued and unpaid interest and additional amounts, if any, at any time upon the occurrence of specified events relating to Brazilian or Dutch tax law, as set forth in this prospectus supplement. See “Description of the Notes—Redemption and Repurchase.”
The notes will be senior unsecured obligations of the issuer, ranking equal in right of payment with all of its other existing and future senior unsecured debt. The guarantee will be senior unsecured obligations of Embraer, ranking equal in right of payment with all of its other existing and future senior unsecured debt.
We will apply to list the notes on the New York Stock Exchange, or NYSE. We cannot assure you that our listing application with the NYSE will be approved.
Investing in the notes involves risks. See “Item 3. Key Information—D. Risk Factors” on page 4 of our annual report on Form 20-F for the year ended December 31, 2023, which is incorporated by reference in this prospectus supplement, and “Risk Factors” beginning on page S-12 of this prospectus supplement to read the discussion of material risks you should consider before investing in the notes.
| | | | | | | | |
| | Per Note | | | Total | |
Public Offering Price(1) | | | | % | | US$ | | |
Underwriting Discount | | | | % | | US$ | | |
Proceeds before expenses to us | | | | % | | US$ | | |
(1) | Plus accrued interest, if any, from , 2025, if settlement occurs after that date. |
Neither the U.S. Securities and Exchange Commission, or the SEC, nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is accurate or complete. Any representation to the contrary is a criminal offense.
We expect the notes to be delivered to purchasers on or about , 2025 in book-entry form only through the facilities of The Depository Trust Company, or DTC, for the accounts of its direct and indirect participants, including Euroclear Bank S.A./N.V., or Euroclear and Clearstream Banking, société anonyme, or Clearstream.
Global Coordinators & Joint Book-Running Managers
| | | | |
Citigroup | | Goldman Sachs & Co. LLC | | J.P. Morgan |
| | | | | | |
| | Morgan Stanley | | PNC Capital Markets LLC | | |
Joint Book-Running Managers
| | | | | | |
BofA Securities | | Bradesco BBI | | Credit Agricole CIB | | Santander |
The date of this prospectus supplement is , 2025.